tradmap

AVTR Avantor, Inc.

$15.20 +3.65%

Updated

Healthcare · Laboratory Analytical Instruments

Avantor, Inc. (AVTR) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $10.4 billion. Shares last traded at $15.20, 4.6% below their 52-week high. Over the past year the stock is up 18.4%. Net profit margin is -8.4%, below the peer median of -1.7%. Revenue declined 3.4% year over year.

Market Cap
$10.4B
Shares Out
682.8M
EPS (TTM)
$-0.52
P/E Ratio
P/S Ratio
1.58
P/B Ratio
1.86
Dividend / Share
Dividend Yield
52-Week High
$15.93
52-Week Low
$7.27
Volume
718,087
Avg Vol (3m)
796,466.381

Performance

1W
+4.04%
1M
+13.82%
3M
+59.44%
6M
+78.35%
YTD
+32.65%
1Y
+18.43%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
71.55
SMA (50)
$12.52
SMA (200)
$10.35
Price vs SMA50
+21.40%
Price vs SMA200
+46.87%
ATR (14)
$0.45

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$6.6B
Net Income
$-551M
Gross Margin
32.1%
Operating Margin
-4.5%
Net Margin
-8.4%
Return on Equity
-9.9%
Return on Assets
-4.7%
Current Ratio
1.76
Debt / Equity
0.68
Revenue Growth (YoY)
-3.4%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.06 2026-04-29
FY 2025 $-0.78 2026-02-11
Q3 2025 $-0.86 2025-10-29
Q2 2025 $0.19 2025-08-01
Q1 2026 $0.09 2026-04-29
FY 2025 $1.04 2026-02-11

Full earnings history →

Laboratory Analytical Instruments peers

AVTR vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
1.58 / 5.01 med
-68% discount
Net margin vs peers
-8.4% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.